October 2016
ASLME Insider: Your Health Law Home
ASLME Home JOIN NOW Forward Issue to a Friend Manage Your eNewsletter Subscription Search Back Issues
 
In This Issue
JLME Announces a New Editor-in-Chief
Job Posting
Postdoctoral/Post Baccalaureate Bioethics Fellowship at the NIH
Tenure Track Position at Saint Louis University School of Law
Announcements
JLME Call for Papers: Symposium Issue on Stigma and Health
Indiana Health Law Review Symposium
Call for Abstracts: The 4th ELSI Congress
Conferences & Events
Next Public Health Law Webinar on October 20th
Katie's Korner
Publications
Where in the World is JLME?
Membership
Ways to Save on ASLME Membership
Connect With Us
facebook twitter linkedin
JLME Announces a New Editor-in-Chief

The American Society of Law, Medicine & Ethics is proud to announce that Aaron S. Kesselheim, M.D., J.D., M.P.H., will be the next Editor-in-Chief of The Journal of Law, Medicine & Ethics, beginning on January 1, 2017.

Aaron is an influential scholar whose work has addressed a number of topics at the intersection of law, medicine, and ethics, including FDA regulatory policies and the approval process for prescription drugs and medical devices, and the costs, availability, and evidence-based use of prescription drugs. He has been published many times in JLME and has a history of service to ASLME both with his current membership on our Board of Directors and in co-chairing (with David Orentlicher) our 2011 conference on Conflicts of Interest in Medicine in Pittsburgh. Aaron will work closely with JLME Editor Ted Hutchinson and Assistant Editor Courtney McClellan in readying the journal for its fifth decade of publication, and will ensure that the journal continues to ask the right questions at an important moment in the history of our fields.

Aaron is an Associate Professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital (BWH). He graduated from Harvard College and received his postgraduate training at the University of Pennsylvania School of Medicine and Law School, and most recently at the Harvard School of Public Health. He is Board Certified in Internal Medicine, and serves as a primary care physician at the Phyllis Jen Center for Primary Care at BWH. Within the Division, Aaron created and leads the Program On Regulation, Therapeutics, And Law (PORTAL), an interdisciplinary research core focusing on intersections among prescription drugs and medical devices, patient health outcomes, and regulatory practices and the law.  He is a member of the New York State Bar and is a Patent Attorney.

Aaron has received wide recognition for his work.  He has testified before Congress on pharmaceutical policy, medical device regulation, generic drugs, and modernizing clinical trials, and served as a consultant for the NIH, FDA, National Academies of Science, Engineering, and Medicine, USPTO, and numerous state government offices.  In 2010, he received the prestigious Alice S. Hersh New Investigator Award from AcademyHealth, the leading professional organization for health services/policy research. The Hersh award is given annually to an outstanding health services researcher under age 40 in the US. In 2013, Aaron was named a Greenwall Faculty Scholar in Bioethics by the Greenwall Foundation, which supports innovative empirical research in bioethics. In 2016, he was presented with the Research Leadership Award from Brigham and Women’s Hospital, and Harvard Medical School’s young mentor award.

Aaron also serves as a faculty supervisor for the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, a faculty member of the Harvard Center for Bioethics, and a Research Associate in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health. In 2014-2015 and again in 2016-2017, he has served as Visiting Associate Professor of Law at Yale Law School, where he teaches Food and Drug Administration Law. In 2012, he was named to the Perspectives Advisory Board of the New England Journal of Medicine.

On January 1, Aaron will take on the role of EIC from Boston University Professor of Law Kevin Outterson, who has faithfully served the journal as Editor-in-Chief for the last seven years. While he will remain active with ASLME through his board work, and in fact will be president of ASLME in 2017, it must be noted that he led JLME during a critical time of success, when the publication virtually exploded in terms of readers, downloads, and revenue earned. His tenure at JLME must be considered an enormous success. Everyone at ASLME thanks Kevin for his inspired leadership during this time in our publication’s history.

The first Editor-in-Chief of JLME was Professor George Annas of Boston University, who set a high bar for those that would follow in his distinguished footsteps. Among those who have served as Editor-in-Chief of JLME following Professor Annas include Larry Gostin, Steven Miles, Karen Rothenberg, Ellen Wright Clayton, Bernard Lo, Kathleen Boozang, and Sandra Johnson. Kevin Outterson succeeded Sandy, and now Aaron will follow Kevin. 

We hope you will all join us in welcoming JLME’s newest Editor-in-Chief, Dr. Aaron Kesselheim. We look forward to great things in JLME under his stewardship!

 

To ensure delivery of ASLME Insider, please add membership@aslme.org to your email address book or Safe Sender List.If you are still having problems receiving our communications, see our white-listing page for more details.

American Society of Law, Medicine & Ethics
765 Commonwealth Avenue, Suite 1634
Boston, MA 02215